Novel inhibitors of the type 1 transporter for glycine (GlyT1) as antipsychotic agents

This publication has 10 references indexed in Scilit:

• Glycine transporters: crucial roles of pharmacological interest revealed by gene deletion
  Trends in Pharmacological Sciences, 2005
• Glycine transporters: essential regulators of neurotransmission
  Trends in Biochemical Sciences, 2005
• Glycine Site Modulators and Glycine Transporter-1 Inhibitors as Novel Therapeutic Targets for the Treatment of Schizophrenia
  Current Neuropharmacology, 2005
• The synthesis and SAR of 2-arylsulfanyl-phenyl piperazinyl acetic acids as glyT-1 inhibitors
  Bioorganic & Medicinal Chemistry Letters, 2004
• Glutamate as a therapeutic target in psychiatric disorders
  Molecular Psychiatry, 2004
• Glutamate Hypothesis of Schizophrenia and Approach for Possible Therapeutic Drugs
  Current Medicinal Chemistry - Central Nervous System Agents, 2004
• Structure, function and regulation of glycine neurotransporters
  European Journal of Pharmacology, 2003
• Atypical antipsychotics in the treatment of schizophrenic patients
  Expert Review of Neurotherapeutics, 2002
• Genetic aspects of schizophrenia
  Clinical Neuroscience Research, 2001
• The Neuropsychopharmacology of Phencyclidine From NMDA Receptor Hypofunction to the Dopamine Hypothesis of Schizophrenia
  Neuropsychopharmacology, 1999